News

Published on 17 May 2024 on Simply Wall St. via Yahoo Finance

News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA)...


Article preview image

Celebrations may be in order for Prothena Corporation plc (NASDAQ:PRTA) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The analysts have sharply increased their revenue numbers, with a view that Prothena will make substantially more sales than they'd previously expected.

Following the latest upgrade, the current consensus, from the ten analysts covering Prothena, is for revenues of US$15m in 2024, which would reflect a stressful 83% reduction in Prothena's sales over the past 12 months. Per-share losses are expected to explode, reaching US$4.66 per share. However, before this estimates update, the consensus had been expecting revenues of US$13m and US$4.81 per share in losses. We can see there's definitely been a change in sentiment in this update, with the analysts administering a sizeable upgrade to this year's revenue estimates, while at the same time reducing their loss estimates.

NASDAQ.PRTA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus

Prothena Corporation PRTA reported fourth-quarter 2024 loss per share of $1.08, wider than the Za...

Zacks · via Yahoo Finance 21 Feb 2025

Prothena Corporation plc (PTRA): Positioning Among Top Debt-Free Stocks

We recently compiled a list of the 7 Best Debt Free Stocks To Buy. In this article, we are going ...

Insider Monkey · via Yahoo Finance 21 Aug 2024

Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate

Prothena Corporation plc PRTA announced that Bristol Myers BMY has in-licensed exclusive global r...

Zacks via Yahoo Finance 29 May 2024

Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate

Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereb...

Zacks · via Yahoo Finance 18 May 2024

News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA)...

Celebrations may be in order for Prothena Corporation plc (NASDAQ:PRTA) shareholders, with the an...

Simply Wall St. via Yahoo Finance 17 May 2024

Analysts Have Lowered Expectations For Prothena Corporation plc (NASDAQ:PRTA) After Its Latest...

The analysts might have been a bit too bullish on Prothena Corporation plc (NASDAQ:PRTA), given t...

Simply Wall St. via Yahoo Finance 12 May 2024

We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This...

Key Insights Prothena to hold its Annual General Meeting on 14th of MaySalary of US$630.5k is par...

Simply Wall St. via Yahoo Finance 8 May 2024

Prothena (PRTA) Q4 Earnings Miss Estimates on Higher R&D Expense

Prothena Corporation PRTA reported fourth-quarter 2023 loss of $1.26 per share, wider than the Za...

Zacks via Yahoo Finance 1 Mar 2024

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript February 15, 2024 Prothen...

Insider Monkey via Yahoo Finance 17 Feb 2024

Prothena (NASDAQ:PRTA) shareholder returns have been strong, earning 207% in 5 years

The last three months have been tough on Prothena Corporation plc (NASDAQ:PRTA) shareholders, who...

Simply Wall St. via Yahoo Finance 2 Dec 2023